These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 70292)
1. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development. Jondal M; Gunven P Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292 [TBL] [Abstract][Full Text] [Related]
2. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis. Jondal M Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma. Pearson GR; Qualtiere LF; Klein G; Norin T; Bal IS Int J Cancer; 1979 Oct; 24(4):402-6. PubMed ID: 93578 [TBL] [Abstract][Full Text] [Related]
5. Antibody-dependent cell-mediated cytotoxicity against Epstein-Barr virus membrane antigen in African Burkitt's lymphoma. Granlund DJ; Nkrumah F; Perkins IV; Biggar RJ; Levine PH; Fuccillo DA Int J Cancer; 1979 Nov; 24(5):567-71. PubMed ID: 231015 [TBL] [Abstract][Full Text] [Related]
6. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211 [TBL] [Abstract][Full Text] [Related]
7. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. Pearson G; Dewey F; Klein G; Henle G; Henle W J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425 [TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging. Jondal M Clin Exp Immunol; 1977 Jul; 29(1):1-10. PubMed ID: 196801 [TBL] [Abstract][Full Text] [Related]
9. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma. Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662 [TBL] [Abstract][Full Text] [Related]
10. [Epstein-Barr virus associated Burkitt's lymphoma in a French child (author's transl)]. Lenoir G; Philip T; Bornkamm GW; Gillet P; Bryon PA; Bouvier R; Dodat H; Doré JF; Brunat-Mentigny M; Hermier M Nouv Presse Med; 1979 Dec; 8(49):4031-3. PubMed ID: 93275 [TBL] [Abstract][Full Text] [Related]
11. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases]. Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients. Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981 [No Abstract] [Full Text] [Related]
13. The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa. Geser A; Brubaker G; Olwit GW Rev Epidemiol Sante Publique; 1980 Oct; 28(3):307-21. PubMed ID: 6258200 [TBL] [Abstract][Full Text] [Related]
15. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals. Aya T; Mizuno F; Osato T J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949 [TBL] [Abstract][Full Text] [Related]
16. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma. Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896 [TBL] [Abstract][Full Text] [Related]
17. A cluster of Epstein-Barr-virus-associated American Burkitt's lymphoma. Judson SC; Henle W; Henle G N Engl J Med; 1977 Sep; 297(9):464-8. PubMed ID: 196197 [TBL] [Abstract][Full Text] [Related]
18. African Burkitt's lymphoma: a plant, Euphorbia tirucalli, reduces Epstein-Barr virus-specific cellular immunity. Imai S; Sugiura M; Mizuno F; Ohigashi H; Koshimizu K; Chiba S; Osato T Anticancer Res; 1994; 14(3A):933-6. PubMed ID: 8074496 [TBL] [Abstract][Full Text] [Related]
19. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984 [TBL] [Abstract][Full Text] [Related]
20. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients. Morrow RH; Sever JL; Henderson BE Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991 [No Abstract] [Full Text] [Related] [Next] [New Search]